BACKGROUND: We recently proffered that a new syndrome persistent inflammation, immunosuppression, and catabolism syndrome (PICS) has replaced late multiple-organ failure as a predominant phenotype of chronic critical illness. Our goal was to validate this by determining whether severely injured trauma patients with complicated outcomes have evidence of PICS at the genomic level. METHODS: We performed a secondary analysis of the Inflammation and Host Response to Injury database of adults with severe blunt trauma. Patients were classified into complicated, intermediate, and uncomplicated clinical trajectories. Existing genomic microarray data were compared between cohorts using Ingenuity Pathways Analysis. Epidemiologic data and outcomes were also analyzed between cohorts on admission, Day 7, and Day 14. RESULTS: Complicated patients were older, were sicker, and required increased ventilator days compared with the intermediate/uncomplicated patients. They also had persistent leukocytosis as well as low lymphocyte and albumin levels compared with uncomplicated patients. Total white blood cell leukocyte analysis in complicated patients showed that overall genome-wide expression patterns and those patterns on Days 7 and 14 were more aberrant from control subjects than were patterns from uncomplicated patients. Complicated patients also had significant down-regulation of adaptive immunity and up-regulation of inflammatory genes on Days 7 and 14 (vs. magnitude in fold change compared with control and in magnitude compared with uncomplicated patients). On Day 7, complicated patients had significant changes in functional pathways involved in the suppression of myeloid cell differentiation, increased inflammation, decreased chemotaxis, and defective innate immunity compared with uncomplicated patients and controls. Subset analysis of monocyte, neutrophil, and T-cells supported these findings. CONCLUSION: Genomic analysis of patients with complicated clinical outcomes exhibit persistent genomic expression changes consistent with defects in the adaptive immune response and increased inflammation. Clinical data showed persistent inflammation, immunosuppression, and protein depletion. Overall, the data support the hypothesis that patients with complicated clinical outcomes are exhibiting PICS. LEVEL OF EVIDENCE: Epidemiologic study, level III.
BACKGROUND: We recently proffered that a new syndrome persistent inflammation, immunosuppression, and catabolism syndrome (PICS) has replaced late multiple-organ failure as a predominant phenotype of chronic critical illness. Our goal was to validate this by determining whether severely injured traumapatients with complicated outcomes have evidence of PICS at the genomic level. METHODS: We performed a secondary analysis of the Inflammation and Host Response to Injury database of adults with severe blunt trauma. Patients were classified into complicated, intermediate, and uncomplicated clinical trajectories. Existing genomic microarray data were compared between cohorts using Ingenuity Pathways Analysis. Epidemiologic data and outcomes were also analyzed between cohorts on admission, Day 7, and Day 14. RESULTS: Complicated patients were older, were sicker, and required increased ventilator days compared with the intermediate/uncomplicated patients. They also had persistent leukocytosis as well as low lymphocyte and albumin levels compared with uncomplicated patients. Total white blood cell leukocyte analysis in complicated patients showed that overall genome-wide expression patterns and those patterns on Days 7 and 14 were more aberrant from control subjects than were patterns from uncomplicated patients. Complicated patients also had significant down-regulation of adaptive immunity and up-regulation of inflammatory genes on Days 7 and 14 (vs. magnitude in fold change compared with control and in magnitude compared with uncomplicated patients). On Day 7, complicated patients had significant changes in functional pathways involved in the suppression of myeloid cell differentiation, increased inflammation, decreased chemotaxis, and defective innate immunity compared with uncomplicated patients and controls. Subset analysis of monocyte, neutrophil, and T-cells supported these findings. CONCLUSION: Genomic analysis of patients with complicated clinical outcomes exhibit persistent genomic expression changes consistent with defects in the adaptive immune response and increased inflammation. Clinical data showed persistent inflammation, immunosuppression, and protein depletion. Overall, the data support the hypothesis that patients with complicated clinical outcomes are exhibiting PICS. LEVEL OF EVIDENCE: Epidemiologic study, level III.
Authors: Robert J Feezor; Henry V Baker; Michael Mindrinos; Doug Hayden; Cynthia L Tannahill; Bernard H Brownstein; Adrian Fay; Sandra MacMillan; Jason Laramie; Wenzhong Xiao; Lyle L Moldawer; J Perren Cobb; Krzysztof Laudanski; Carol L Miller-Graziano; Ronald V Maier; David Schoenfeld; Ronald W Davis; Ronald G Tompkins Journal: Physiol Genomics Date: 2004-11-17 Impact factor: 3.107
Authors: J Perren Cobb; Michael N Mindrinos; Carol Miller-Graziano; Steve E Calvano; Henry V Baker; Wenzhong Xiao; Krzysztof Laudanski; Bernard H Brownstein; Constance M Elson; Douglas L Hayden; David N Herndon; Stephen F Lowry; Ronald V Maier; David A Schoenfeld; Lyle L Moldawer; Ronald W Davis; Ronald G Tompkins; Henry V Baker; Paul Bankey; Timothy Billiar; Bernard H Brownstein; Steve E Calvano; David Camp; Irshad Chaudry; J Perren Cobb; Ronald W Davis; Constance M Elson; Bradley Freeman; Richard Gamelli; Nicole Gibran; Brian Harbrecht; Douglas L Hayden; Wyrta Heagy; David Heimbach; David N Herndon; Jureta Horton; John Hunt; Krzysztof Laudanski; James Lederer; Stephen F Lowry; Ronald V Maier; John Mannick; Bruce McKinley; Carol Miller-Graziano; Michael N Mindrinos; Joseph Minei; Lyle L Moldawer; Ernest Moore; Frederick Moore; Robert Munford; Avery Nathens; Grant O'keefe; Gary Purdue; Laurence Rahme; Daniel Remick; Matthew Sailors; David A Schoenfeld; Michael Shapiro; Geoffrey Silver; Richard Smith; Gregory Stephanopoulos; Gary Stormo; Ronald G Tompkins; Mehmet Toner; Shaw Warren; Michael West; Steven Wolfe; Wenzhong Xiao; Vernon Young Journal: Proc Natl Acad Sci U S A Date: 2005-03-21 Impact factor: 11.205
Authors: Judith E Nelson; Diane E Meier; Ann Litke; Dana A Natale; Robert E Siegel; R Sean Morrison Journal: Crit Care Med Date: 2004-07 Impact factor: 7.598
Authors: Brittany Mathias; Amber L Delmas; Tezcan Ozrazgat-Baslanti; Erin L Vanzant; Benjamin E Szpila; Alicia M Mohr; Frederick A Moore; Scott C Brakenridge; Babette A Brumback; Lyle L Moldawer; Philip A Efron Journal: Ann Surg Date: 2017-04 Impact factor: 12.969
Authors: C D Barrett; A T Hsu; C D Ellson; B Y Miyazawa; Y-W Kong; J D Greenwood; S Dhara; M D Neal; J L Sperry; M S Park; M J Cohen; B S Zuckerbraun; M B Yaffe Journal: Clin Exp Immunol Date: 2018-09-09 Impact factor: 4.330
Authors: Juan C Mira; Joseph Cuschieri; Tezcan Ozrazgat-Baslanti; Zhongkai Wang; Gabriela L Ghita; Tyler J Loftus; Julie A Stortz; Steven L Raymond; Jennifer D Lanz; Laura V Hennessy; Babette Brumback; Philip A Efron; Henry V Baker; Frederick A Moore; Ronald V Maier; Lyle L Moldawer; Scott C Brakenridge Journal: Crit Care Med Date: 2017-12 Impact factor: 7.598
Authors: Robert T Mankowski; Stephen D Anton; Gabriela L Ghita; Babette Brumback; Michael C Cox; Alicia M Mohr; Christiaan Leeuwenburgh; Lyle L Moldawer; Philip A Efron; Scott C Brakenridge; Frederick A Moore Journal: J Am Geriatr Soc Date: 2020-04-15 Impact factor: 5.562